Larry Einhorn (Lawrence H. Einhorn, MD)
About Larry Einhorn (Lawrence H. Einhorn, MD)
Larry Einhorn (Lawrence H. Einhorn, MD) is a distinguished medical oncologist, cancer researcher, physician, and educator associated with Indiana University School of Medicine and the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Larry Einhorn (Lawrence H. Einhorn, MD) is internationally recognized for his pioneering work in testicular cancer, particularly research that helped establish cisplatin-based chemotherapy as a highly effective treatment for metastatic testicular cancer. His work at Indiana University contributed significantly to the transformation of testicular cancer treatment and long-term survival.
His career has combined clinical oncology, cancer research, medical education, and mentorship. His documented research interests include testicular cancer as well as bladder, prostate, lung, gastrointestinal, and breast cancers.
Larry Einhorn (Lawrence H. Einhorn, MD) Profile
- Full Name: Lawrence H. Einhorn, MD
- Commonly Known As: Larry Einhorn
- Primary Name Format: Larry Einhorn (Lawrence H. Einhorn, MD)
- Specialty: Medical Oncology
- Additional Specialty: Internal Medicine
- Provider Type: Physician
- Academic Institution: Indiana University School of Medicine
- Cancer Center: Indiana University Melvin and Bren Simon Comprehensive Cancer Center
- Academic Titles: IU Distinguished Professor; Livestrong Foundation Professor of Oncology; Professor of Medicine
- Location: Indianapolis, Indiana
- Medical School: University of Iowa
- Medical School Graduation: 1968
- Oncology Fellowship: Indiana University Medical Center, 1971–1972
- Oncology Fellowship: M.D. Anderson, Houston, Texas, 1972–1973
- Board Certification: Internal Medicine
- Board Certification: Medical Oncology
- Professional Organization: American Society of Clinical Oncology
- Primary Research Focus: Testicular cancer and germ-cell tumors
- Additional Research Interests: Bladder cancer, prostate cancer, lung cancer, gastrointestinal tumors, breast cancer, and cancer survivorship
Specialty
Medical Oncology
Larry Einhorn (Lawrence H. Einhorn, MD) has spent much of his professional career in medical oncology, with particular emphasis on testicular cancer and germ-cell tumors.
His documented research interests include:
- Testicular cancer
- Germ-cell tumors
- Bladder cancer
- Prostate cancer
- Lung cancer
- Gastrointestinal cancers
- Breast cancer
- Adult oncology
- Cancer treatment
- Cancer survivorship
- Long-term effects of chemotherapy
His work has included both patient care and clinical research focused on improving cancer treatment and outcomes.
Larry Einhorn (Lawrence H. Einhorn, MD) and Testicular Cancer
Larry Einhorn (Lawrence H. Einhorn, MD) is particularly associated with major advances in the treatment of metastatic testicular cancer.
During the 1970s, metastatic testicular cancer had a poor prognosis. Research led by Larry Einhorn helped establish a combination chemotherapy approach incorporating cisplatin, a platinum-based chemotherapy drug, that dramatically improved treatment outcomes.
This work became an important milestone in modern oncology and helped establish testicular cancer as one of the most curable forms of advanced cancer.
Indiana University reports that more than 95% of patients with testicular cancer can now be cured through surgery or chemotherapy, reflecting decades of progress in treatment.
The Importance of Cisplatin-Based Treatment
Cisplatin became a foundational component of chemotherapy for testicular cancer. The treatment approach associated with Larry Einhorn’s work also influenced the use of platinum-based chemotherapy in other types of cancer.
His research subsequently extended beyond initial treatment success to questions about how cancer therapy affects patients over the long term.
Medical Education
Larry Einhorn (Lawrence H. Einhorn, MD) earned his medical degree from the University of Iowa in 1968.
His postgraduate oncology training included fellowships at Indiana University Medical Center and M.D. Anderson in Houston.
Medical School
- Institution: University of Iowa
- Degree: Doctor of Medicine
- Year: 1968
Oncology Fellowship Training
- Indiana University Medical Center: 1971–1972
- M.D. Anderson, Houston, Texas: 1972–1973
This training formed the foundation for a career combining clinical oncology, cancer research, education, and academic medicine.
Academic Career
Larry Einhorn (Lawrence H. Einhorn, MD) joined the faculty of Indiana University School of Medicine in 1973 as its first medical oncologist.
His long academic career has included clinical research, patient care, physician education, and leadership in oncology.
His academic titles include:
- IU Distinguished Professor
- Livestrong Foundation Professor of Oncology
- Professor of Medicine
He is also associated with the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Cancer Research
Larry Einhorn (Lawrence H. Einhorn, MD) has conducted and contributed to research involving several areas of adult oncology.
Research Interests
His documented areas of research include:
- Testicular cancer
- Germ-cell tumors
- Bladder cancer
- Prostate cancer
- Lung cancer
- Gastrointestinal tumors
- Breast cancer
- Cancer treatment
- Cancer survivorship
- Long-term treatment effects
His work has addressed both the effectiveness of cancer treatment and the longer-term health considerations faced by cancer survivors.
Cancer Survivorship Research
An important part of Larry Einhorn (Lawrence H. Einhorn, MD)’s later research has involved understanding the long-term effects of cancer treatment.
The Platinum Study examines long-term health effects among testicular cancer survivors who received cisplatin-based chemotherapy.
Research in this area has examined treatment-related concerns such as:
- Neuropathy
- Hearing-related effects
- Cardiovascular health
- Other long-term treatment toxicities
The broader goal of this research is to help physicians understand how successful cancer treatment can affect patients years after treatment has ended.
Clinical Focus
Larry Einhorn (Lawrence H. Einhorn, MD)’s professional and research interests have particularly focused on complex adult cancers and solid tumors.
Areas associated with his work include:
- Testicular cancer
- Germ-cell tumors
- Bladder cancer
- Prostate cancer
- Lung cancer
- Gastrointestinal tumors
- Breast cancer
- Metastatic cancer
- Cancer survivorship
- Long-term effects of cancer treatment
Cancer treatment decisions depend on an individual’s diagnosis, cancer stage, previous therapies, overall health, and other clinical considerations.
Leadership in Oncology
Larry Einhorn (Lawrence H. Einhorn, MD) has contributed to the oncology profession through clinical research, medical education, and professional leadership.
He served as President of the American Society of Clinical Oncology from 2000 to 2001.
His professional career has also included extensive involvement in oncology education and the development of future cancer specialists.
Mentorship and Medical Education
Medical education has been an important part of Larry Einhorn (Lawrence H. Einhorn, MD)’s career.
He helped establish the Indiana University hematology-oncology fellowship program in the 1970s. The program has subsequently trained generations of physicians who have pursued careers in academic medicine, clinical oncology, and cancer research.
His educational contributions have extended beyond formal fellowship training to mentorship and professional development for physicians entering the field of oncology.
Awards and Honors
Larry Einhorn (Lawrence H. Einhorn, MD) has received numerous professional honors during his career.
Documented recognitions include:
- American Cancer Society Medal of Honor – 1983
- Association of American Physicians – elected member, 1985
- Milken Foundation Distinguished Clinician Award – 1989
- Kettering Prize for Cancer Research – 1992
- David A. Karnofsky Memorial Award – 2000
- National Academy of Sciences – elected member, 2001
- Ted Couch Cancer Research Award – 2010
These honors recognize contributions to cancer treatment, research, and medical education.
Professional Contributions
Larry Einhorn (Lawrence H. Einhorn, MD)’s career encompasses several major areas of oncology.
Clinical Oncology
His clinical career has focused on caring for patients with complex cancers, particularly germ-cell tumors and testicular cancer.
Cancer Research
His research helped establish highly effective cisplatin-based treatment for metastatic testicular cancer and later expanded into cancer survivorship and treatment-related effects.
Medical Education
He has helped educate and mentor generations of oncologists through Indiana University.
Professional Leadership
His leadership in organized oncology included serving as president of the American Society of Clinical Oncology.
Practice and Academic Location
Larry Einhorn (Lawrence H. Einhorn, MD)’s institutional profile has listed his professional location as:
535 Barnhill Drive
RT 473
Indianapolis, IN 46202
Phone: (317) 944-0920
Fax: (317) 944-3646
Current appointment availability, clinical services, and referral requirements should be confirmed directly with the relevant institution.
Legacy in Cancer Treatment
Larry Einhorn (Lawrence H. Einhorn, MD)’s name is closely associated with one of the major developments in modern testicular cancer treatment.
His work in the 1970s helped establish cisplatin-based chemotherapy as an effective treatment for metastatic testicular cancer. This contributed to dramatic improvements in survival for patients with the disease.
His career has also emphasized an important second goal of cancer research: understanding how to reduce the long-term effects of treatment for people who survive cancer.
Frequently Asked Questions
Who is Larry Einhorn (Lawrence H. Einhorn, MD)?
Larry Einhorn (Lawrence H. Einhorn, MD) is a medical oncologist, cancer researcher, physician, and educator associated with Indiana University School of Medicine and the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Is Larry Einhorn the same person as Lawrence H. Einhorn?
Yes. Larry Einhorn is the commonly used name of Lawrence H. Einhorn, MD. Both names refer to the same physician.
What is Larry Einhorn (Lawrence H. Einhorn, MD) known for?
He is particularly known for pioneering work in testicular cancer treatment, including research involving cisplatin-based chemotherapy for metastatic testicular cancer.
What does Larry Einhorn specialize in?
Larry Einhorn (Lawrence H. Einhorn, MD) is associated with medical oncology, with a particular focus on testicular cancer and germ-cell tumors.
Where did Larry Einhorn attend medical school?
He earned his medical degree from the University of Iowa in 1968.
Where did Larry Einhorn complete his oncology training?
His oncology fellowship training included Indiana University Medical Center from 1971 to 1972 and M.D. Anderson in Houston from 1972 to 1973.
When did Larry Einhorn join Indiana University?
Larry Einhorn joined the Indiana University School of Medicine faculty in 1973 as its first medical oncologist.
Did Larry Einhorn serve as president of ASCO?
Yes. Larry Einhorn (Lawrence H. Einhorn, MD) served as president of the American Society of Clinical Oncology from 2000 to 2001.
What cancers has Larry Einhorn researched?
His documented research interests include:
- Testicular cancer
- Germ-cell tumors
- Bladder cancer
- Prostate cancer
- Lung cancer
- Gastrointestinal tumors
- Breast cancer
Is Larry Einhorn involved in cancer survivorship research?
Yes. His research has included the long-term effects of cancer treatment, including research involving testicular cancer survivors who received cisplatin-based chemotherapy.
Where is Larry Einhorn based?
His institutional profile lists his professional location in Indianapolis, Indiana, at 535 Barnhill Drive, RT 473.
What is Larry Einhorn’s connection to Indiana University?
Larry Einhorn has had a long academic career at Indiana University School of Medicine. He joined the faculty in 1973 and has held senior academic positions while contributing to cancer research, patient care, and oncology education.
What type of cancer treatment is Larry Einhorn associated with?
Larry Einhorn (Lawrence H. Einhorn, MD) is particularly associated with cisplatin-based chemotherapy for metastatic testicular cancer and research into improving treatment outcomes and reducing long-term treatment effects.
Reviews
There are no reviews yet.